Healthy Returns: How competitive can Roche be in the weight loss drug market?

Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.

Sep 18, 2024 - 10:00

0 3

Healthy Returns: How competitive can Roche be in the weight loss drug market?

Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.

Tags:

Previous Article

U.S. crude oil rises more than 1%, closes above $71 per barrel amid Fed rate cut...

Rate cut is already baked into mortgage rates, says Rocket Companies CEO Varun K...

admin

admin

This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.